Key facts
- This page summarizes Santiago Arroyo's Form 3 filing for Fulcrum Therapeutics, Inc. (FULC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Nov 2022, 15:10.
Santiago Arroyo - 07 Nov 2022 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- FULC
- Reported as of
- 07 Nov 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 09 Nov 2022, 15:10:10 UTC
- Prior SEC filing
- 07 Feb 2022
- Next SEC filing
- 04 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Greg Tourangeau, as attorney-in-fact for Santiago Arroyo
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Santiago Arroyo filed Form 3 for Fulcrum Therapeutics, Inc. (FULC) on 09 Nov 2022.
Change
- Previous filing in this sequence was filed on 07 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FULC
holding
No securities are beneficially owned
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 07 Nov 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit Index: 24.1 Power of Attorney